QA: Altrazeal Life Sciences Inc in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001168220_2014_Altrazeal_Life_Sciences_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001168220, Altrazeal Life Sciences Inc

  xvar xval
0 AssetsCurrent 1,487,324
1 IntangibleAssetsNetIncludingGoodwill 3,670,837
2 PropertyPlantAndEquipmentNet 638,614
3 remainder_Assets 104,839
4 LiabilitiesCurrent 3,270,064
5 LiabilitiesNoncurrent 898,133
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,288,050
9 ResearchAndDevelopmentExpense 788,242
10 remainder_Expenses 1,448,503
11 remainder_Revenues 370,568
12 remainder_NetIncome 73,313
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,901,614
1 Liabilities 4,168,197
2 Expenses 3,524,795
3 Revenues 370,568
4 StockholdersEquity 1,733,417
5 NetIncome -3,080,914
6 ComprehensiveNetIncome -3,080,914
7 BaseVar 7,019,244
8 EconomicCapitalRatiobeforeLimitedLiability 0.139
9 EconomicCapitalRatio 1.55

Edgar->Model Mapping

Feature Distribution

Change over Time